Literature DB >> 15741440

Structural changes to airway smooth muscle in cystic fibrosis.

S R Hays1, R E Ferrando, R Carter, H H Wong, P G Woodruff.   

Abstract

BACKGROUND: Chronic airway obstruction is characteristic of cystic fibrosis (CF) but there are few studies of airway smooth muscle remodelling in CF.
METHODS: Airway smooth muscle content and mean airway smooth muscle cell size were measured by applying design-based stereology to bronchoscopic biopsy specimens obtained from seven subjects with CF and 15 healthy controls.
RESULTS: The smooth muscle content increased by 63% in subjects with CF (mean (SD) 0.173 (0.08) v 0.106 (0.042) mm(3) smooth muscle/mm(3) submucosa, mean difference -0.067; 95% CI -0.12 to -0.013, p = 0.017) but there was no increase in mean cell size (2705 (351) v 2654 (757) microm(3), mean difference -51; 95% CI -687 to 585, p = 0.87).
CONCLUSIONS: These findings indicate hyperplasia of airway smooth muscle cells without hypertrophy and suggest that accumulation of airway smooth muscle cells may contribute to airway narrowing and bronchial hyperresponsiveness in CF.

Entities:  

Mesh:

Year:  2005        PMID: 15741440      PMCID: PMC1747321          DOI: 10.1136/thx.2004.028340

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  14 in total

Review 1.  Airway smooth muscle in health and disease; methods of measurement and relation to function.

Authors:  A James; N Carroll
Journal:  Eur Respir J       Date:  2000-04       Impact factor: 16.671

2.  Applying stereology to measure thickness of the basement membrane zone in bronchial biopsy specimens.

Authors:  Ronald E Ferrando; Jens R Nyengaard; Steven R Hays; John V Fahy; Prescott G Woodruff
Journal:  J Allergy Clin Immunol       Date:  2003-12       Impact factor: 10.793

3.  Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression.

Authors:  Prescott G Woodruff; Gregory M Dolganov; Ronald E Ferrando; Samantha Donnelly; Steven R Hays; Owen D Solberg; Roderick Carter; Hofer H Wong; Peggy S Cadbury; John V Fahy
Journal:  Am J Respir Crit Care Med       Date:  2004-01-15       Impact factor: 21.405

4.  Quantitative assessment of the epithelial and inflammatory cell populations in large airways of normals and individuals with cystic fibrosis.

Authors:  C Danel; S C Erzurum; N G McElvaney; R G Crystal
Journal:  Am J Respir Crit Care Med       Date:  1996-01       Impact factor: 21.405

Review 5.  Epithelial-mesenchymal interactions in the pathogenesis of asthma.

Authors:  S T Holgate; D E Davies; P M Lackie; S J Wilson; S M Puddicombe; J L Lordan
Journal:  J Allergy Clin Immunol       Date:  2000-02       Impact factor: 10.793

6.  Cartilaginous airway wall dimensions and airway resistance in cystic fibrosis lungs.

Authors:  H A Tiddens; L P Koopman; R K Lambert; W M Elliott; W C Hop; T W van der Mark; W J de Boer; J C de Jongste
Journal:  Eur Respir J       Date:  2000-04       Impact factor: 16.671

7.  The lung in cystic fibrosis. A quantitative study including prevalence of pathologic findings among different age groups.

Authors:  C W Bedrossian; S D Greenberg; D B Singer; J J Hansen; H S Rosenberg
Journal:  Hum Pathol       Date:  1976-03       Impact factor: 3.466

8.  Bronchial reactivity in cystic fibrosis with normal pulmonary function.

Authors:  P Van Asperen; C M Mellis; R T South; S J Simpson
Journal:  Am J Dis Child       Date:  1981-09

9.  Bronchial hyperreactivity in cystic fibrosis and asthma.

Authors:  I Mitchell; M Corey; R Woenne; I R Krastins; H Levison
Journal:  J Pediatr       Date:  1978-11       Impact factor: 4.406

10.  Reversible airway obstruction in cystic fibrosis.

Authors:  L P Ormerod; R A Thomson; C M Anderson; D E Stableforth
Journal:  Thorax       Date:  1980-10       Impact factor: 9.139

View more
  15 in total

1.  Fibrocyte accumulation in the lungs of cystic fibrosis patients.

Authors:  Rajesh K Kasam; Prathibha R Gajjala; Anil G Jegga; Jennifer A Courtney; Scott H Randell; Elizabeth L Kramer; John P Clancy; Satish K Madala
Journal:  J Cyst Fibros       Date:  2020-06-25       Impact factor: 5.482

2.  Characterizing mucous cell remodeling in cystic fibrosis: relationship to neutrophils.

Authors:  Steven R Hays; John V Fahy
Journal:  Am J Respir Crit Care Med       Date:  2006-08-17       Impact factor: 21.405

3.  Loss of cystic fibrosis transmembrane conductance regulator function produces abnormalities in tracheal development in neonatal pigs and young children.

Authors:  David K Meyerholz; David A Stoltz; Eman Namati; Shyam Ramachandran; Alejandro A Pezzulo; Amanda R Smith; Michael V Rector; Melissa J Suter; Simon Kao; Geoffrey McLennan; Guillermo J Tearney; Joseph Zabner; Paul B McCray; Michael J Welsh
Journal:  Am J Respir Crit Care Med       Date:  2010-07-09       Impact factor: 21.405

4.  Mechanical stretch up-regulates microRNA-26a and induces human airway smooth muscle hypertrophy by suppressing glycogen synthase kinase-3β.

Authors:  Junaith S Mohamed; Michael A Lopez; Aladin M Boriek
Journal:  J Biol Chem       Date:  2010-06-03       Impact factor: 5.157

5.  Acute administration of ivacaftor to people with cystic fibrosis and a G551D-CFTR mutation reveals smooth muscle abnormalities.

Authors:  Ryan J Adam; Katherine B Hisert; Jonathan D Dodd; Brenda Grogan; Janice L Launspach; Janel K Barnes; Charles G Gallagher; Jered P Sieren; Thomas J Gross; Anthony J Fischer; Joseph E Cavanaugh; Eric A Hoffman; Pradeep K Singh; Michael J Welsh; Edward F McKone; David A Stoltz
Journal:  JCI Insight       Date:  2016-04-07

6.  Desmin regulates airway smooth muscle hypertrophy through early growth-responsive protein-1 and microRNA-26a.

Authors:  Junaith S Mohamed; Ameena Hajira; Zhenlin Li; Denise Paulin; Aladin M Boriek
Journal:  J Biol Chem       Date:  2011-09-07       Impact factor: 5.157

7.  Cytosolic phospholipase A2alpha mediates Pseudomonas aeruginosa LPS-induced airway constriction of CFTR -/- mice.

Authors:  Yong-Zheng Wu; Mohammad Abolhassani; Mario Ollero; Fariel Dif; Naonori Uozumi; Micheline Lagranderie; Takao Shimizu; Michel Chignard; Lhousseine Touqui
Journal:  Respir Res       Date:  2010-04-29

Review 8.  Arginase and pulmonary diseases.

Authors:  Harm Maarsingh; Tonio Pera; Herman Meurs
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-04-24       Impact factor: 3.000

9.  Airway remodelling in children with cystic fibrosis.

Authors:  Tom N Hilliard; Nicolas Regamey; Janis K Shute; Andrew G Nicholson; Eric W F W Alton; Andrew Bush; Jane C Davies
Journal:  Thorax       Date:  2007-05-25       Impact factor: 9.139

10.  LncRNA GAS5 attenuates fibroblast activation through inhibiting Smad3 signaling.

Authors:  Rui Tang; Yung-Chun Wang; Xiaohan Mei; Ning Shi; Chenming Sun; Ran Ran; Gui Zhang; Wenjing Li; Kevin F Staveley-O'Carroll; Guangfu Li; Shi-You Chen
Journal:  Am J Physiol Cell Physiol       Date:  2020-05-06       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.